Join to View Full Profile
1100 9th AveSeattle, WA 98101
Phone+1 206-223-6600
Dr. Porter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Rhode Island Hospital/Brown University HealthResidency, Urology, 1993 - 1997- Rhode Island Hospital/Brown University HealthResidency, Surgery, 1992 - 1993
Miriam HospitalInternship, Transitional Year, 1990 - 1991
Rush Medical College of Rush University Medical CenterClass of 1990
Certifications & Licensure
HI State Medical License 2022 - 2028
WA State Medical License 2002 - 2027
TX State Medical License 2023 - 2026
AK State Medical License 2003 - 2022
NY State Medical License 1997 - 2004
DC State Medical License 2000 - 2000
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Powerchart, Cerner Healthe and IQHealth, Cerner Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2012, 2014, 2016-2017
Clinical Trials
- Childhood Cancer Predisposition Study (CCPS) Start of enrollment: 2021 Apr 22
Publications & Presentations
PubMed
- 6 citationsThe effect of race on treatment patterns and subsequent health-related quality of life outcomes in men undergoing treatment for localized prostate cancer.Natasza M Posielski, Santosh Shanmuga, On Ho, Jiji Jiang, Sally Elsamanoudi
Prostate Cancer and Prostatic Diseases. 2023-06-01 - Are high-risk prostate cancer patients being treated equally? The impact of PSA.Eyal Kord, Basil Ferenczi, Renzo G DiNatale, Adam Daily, Hannah Koenig
Urologic Oncology. 2023-04-01 - 4 citationsThe role of multiparametric ultrasound in the detection of clinically significant prostate cancer.Nathan Jung, Renzo G DiNatale, Jason Frankel, Hannah Koenig, On Ho
World Journal of Urology. 2023-03-01
Press Mentions
'Active Surveillance' of Prostate Cancer Doesn't Dampen Quality of LifeJuly 29th, 2016
'Active Surveillance' of Prostate Cancer Doesn't Dampen Quality of LifeJuly 28th, 2016
PCa Active Surveillance Patients Enjoy Good Quality of LifeJuly 27th, 2016
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
